このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Meta Health 過去の業績

過去基準チェック /06

Meta Healthの収益は年間平均-20%の割合で減少していますが、 Machinery業界の収益は年間増加しています。収益は年間12% 14.6%割合で減少しています。

主要情報

-20.0%

収益成長率

-6.5%

EPS成長率

Machinery 業界の成長	12.0%
収益成長率	-14.6%
株主資本利益率	n/a
ネット・マージン	-73.6%
前回の決算情報	31 Dec 2023

Recent updates

収支内訳

Meta Health の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。

収益と収入の歴史

Catalist:5DX 収益、費用、利益 ( )SGD Millions
日付	収益	収益	G+A経費
31 Dec 23	5	-3	3
30 Jun 23	28	-8	11
31 Mar 23	31	-8	12
31 Dec 22	11	-7	5
30 Sep 22	38	-5	13
30 Jun 22	42	-2	14
31 Mar 22	42	0	13
31 Dec 21	43	1	13
30 Sep 21	41	4	12
30 Jun 21	39	0	11
31 Mar 21	35	-1	11
31 Dec 20	32	-2	11
30 Sep 20	34	-2	11
30 Jun 20	36	-2	12
31 Mar 20	41	-1	13
31 Dec 19	45	0	13
30 Sep 19	46	-1	15
30 Jun 19	46	-3	16
31 Mar 19	47	-4	17
31 Dec 18	47	-5	18
30 Sep 18	49	-6	18
30 Jun 18	51	-6	19
31 Mar 18	53	-7	20
31 Dec 17	56	-9	20
30 Sep 17	58	-8	20
30 Jun 17	61	-6	21
31 Mar 17	57	-4	19
31 Dec 16	53	-2	18
30 Jun 16	47	1	14
31 Mar 16	50	1	14
31 Dec 15	52	1	14
30 Sep 15	60	0	18
30 Jun 15	61	-1	18
31 Mar 15	65	-2	20
31 Dec 14	69	-3	21
30 Sep 14	70	-3	21
30 Jun 14	71	-2	21
31 Mar 14	70	-1	20
31 Dec 13	69	0	20
30 Sep 13	68	1	18

質の高い収益: 5DXは現在利益が出ていません。

利益率の向上: 5DXは現在利益が出ていません。

フリー・キャッシュフローと収益の比較

過去の収益成長分析

収益動向: 5DXは利益が出ておらず、過去 5 年間で損失は年間20%の割合で増加しています。

成長の加速: 5DXの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。

収益対業界: 5DXは利益が出ていないため、過去 1 年間の収益成長をMachinery業界 ( -11% ) と比較することは困難です。

株主資本利益率

高いROE: 5DXの負債は資産を上回っているため、自己資本利益率を計算することは困難です。

Meta Health 過去の業績

過去 基準チェック /06

主要情報

最近の業績更新

Full year 2023 earnings released: S$0.004 loss per share (vs S$0.016 loss in FY 2022)

First half 2023 earnings released: S$0.004 loss per share (vs S$0.005 loss in 1H 2022)

Full year 2022 earnings released: S$0.013 loss per share (vs S$0.018 profit in FY 2021)

Meta Health Limited to Report Fiscal Year 2022 Results on Mar 01, 2023

First half 2022 earnings released

Full year 2021 earnings released: EPS: S$0.018 (vs S$0.005 loss in FY 2020)

Recent updates

New major risk - Share price stability

Meta Health Limited Announces the Appointment of Cheah You Kong as the Acting Head of Finance and as an Executive Officer, Effective May 1, 2024

Meta Health Limited, Annual General Meeting, Apr 29, 2024

High number of new directors

Meta Health Limited Announces Resignation of Tan Sze Leng as Chief Financial Officer, Effective from 17 May 2024

New major risk - Negative shareholders equity

Full year 2023 earnings released: S$0.004 loss per share (vs S$0.016 loss in FY 2022)

New minor risk - Financial data availability

Meta Health Limited Announces the Cessation of Mr. Chua Kheng Choon as Senior Vice President of Engineering

High number of new and inexperienced directors

New major risk - Shareholder dilution

High number of new and inexperienced directors

Meta Health Limited Appoints Lim Qing Ru as Independent Non-Executive Director, Member of the Audit Committee, the Nominating Committee and the Remuneration Committee, Effective from 1 November 2023

New major risk - Share price stability

New major risk - Revenue and earnings growth

First half 2023 earnings released: S$0.004 loss per share (vs S$0.005 loss in 1H 2022)

New major risk - Share price stability

Full year 2022 earnings released: S$0.013 loss per share (vs S$0.018 profit in FY 2021)

Meta Health Limited to Report Fiscal Year 2022 Results on Mar 01, 2023

Meta Health Limited Announces Resignation of Mak Peng Leong Philip as Joint Company Secretary, Effect from 12 December 2022

Executive Chairman & Group CEO recently bought S$59k worth of stock

Meta Health Limited Appoints Tan Sze Leng as Chief Financial Officer, Effective from 21 September 2022

Executive Chairman & Group CEO recently bought S$59k worth of stock

First half 2022 earnings released

Meta Health Limited Provides Financial Guidance for the First Half Year Ended June 30, 2022

High number of new and inexperienced directors

Meta Health Limited Announces Appointment of Law Ren Kai Kenneth as Independent Non-Executive Director, Chairman of the Audit Committee, and A Member of the Nominating Committee and the Remuneration Committee

Meta Health Limited Announces Resignation of Mak Peng Leong Philip as Joint Company Secretary, Effective 12 December 2022

Meta Health Limited Announces Resignation Leow Siew Yon, Cynthia as Independent Non-Executive Director, Chairman of the Nominating Committee, and a Member of the Audit Committee and the Remuneration Committee

Meta Health Limited Announces Management Changes

Full year 2021 earnings released: EPS: S$0.018 (vs S$0.005 loss in FY 2020)

Meta Health Limited, Annual General Meeting, Apr 28, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Now 23% undervalued after recent price drop

Metal Precision Services Pte Ltd. completed the acquisition of 85.07% stake in Gainhealth Pte. Ltd. from Jagannathan Padmaja Sakthi, Fu Yijie and Yeo Kang Nian.

Metal Component Engineering Limited (Catalist:5DX) agreed to acquire Gainhealth Pte. Ltd. from Jagannathan Padmaja Sakthi, Fu Yijie and Yeo Kang Nian for SGD 11.1 million.

Metal Component Engineering Considers Potential Acquisition

Independent Non-Executive Director has left the company

Full year 2020 earnings released

Metal Component Engineering Limited Announces Board Changes, Effective January 1, 2021

Metal Component Engineering Limited Provides Group Earnings Guidance for the Half Year Ended 30 June 2020

Metal Component Engineering Limited to Report First Half, 2020 Results on Aug 14, 2020

収支内訳

収益と収入の歴史

フリー・キャッシュフローと収益の比較

過去の収益成長分析

株主資本利益率

総資産利益率

使用総資本利益率

過去の好業績企業の発掘

過去基準チェック /06